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Abstract: Purpose: To retrospectively evaluate the technical and clinical outcome of patients with
symptomatic postoperative fluid collections following liver resection treated with CT-guided drainage
(CTD). Methods: 143 suitable patients were examined between 2004 and 2017. Technical success
was defined as (a) sufficient drainage of the fluid collection and (b) the non-occurrence of peri-
interventional complications requiring surgical treatment with minor or prolonged hospitalization.
Clinical success was defined as (a) decreasing or normalization of specific blood parameters within
30 days after intervention and (b) no surgical revision in addition to intervention required. C-reactive
protein (CRP), leukocytes and Total Serum Bilirubin (TSB) were assessed. Dose length product (DLP)
for the intervention parts was determined. Results: Technical success was achieved in 99.5% of 189
performed interventions. Clinical success was reached in 74% for CRP, in 86.7% for Leukocytes and
in 62.1% for TSB. The median of successful decrease was 6.0 days for CRP, 3.5 days for Leukocytes
and 5.5 days for TSB. In 90.2%, no surgical revision was necessary. Total DLP was significantly lower
in the second half of the observation period (median 536.0 mGy*cm between years 2011 and 2017 vs.
median 745.5 mGy*cm between years 2004 and 2010). Conclusions: Technical success rate of CTD
was very high, and clinical success rate was fair to good. Reduction of the radiation dose reflects
developments of CT technology and increased experience of the interventional radiologists.
Keywords: technical outcome; clinical outcome; CT-guided drainage; liver resection; fluid collection
1. Introduction
After liver resections, intraabdominal fluid collections frequently occur [1]. The most
frequent pathologies are seroma, lymphocele, hematoma or biloma [2]. If infected, abscess
formations can cause substantial morbidity and mortality [3]. Computed tomography
(CT) is an appropriate method to evaluate fluid collections and to decide about further
treatment [4].
In addition to antibiotic therapy, the most appropriate therapeutic method is percu-
taneous drainage. It allows to precisely target the site of the fluid collection and thereby
prevent further complications, for example, necrosis of liver parenchyma [5–7].
Percutaneous drainage under CT guidance is a minimally invasive procedure, which
is well tolerated by the patients and should therefore be preferred over open surgical
drainage [3,8,9]. The technical success rates of percutaneous drainage, as reported in
Diagnostics 2021, 11, 826. https://doi.org/10.3390/diagnostics11050826 https://www.mdpi.com/journal/diagnostics
Diagnostics 2021, 11, 826 2 of 13
the scientific literature, are very high [5,10,11]. However, various procedure-associated
complications of this intervention, such as hemorrhage and sepsis, may occur [6,12–15].
There are several studies that evaluated the clinical outcome of percutaneous CT-
guided drainage (CTD) of intraabdominal abscesses of varying etiologies, including ab-
scesses that were not associated with operation. Most reports confirmed high rates of
clinical success [5,11]. A drawback of these studies was rather small patient collectives.
The aim of our study was to retrospectively evaluate the technical and clinical outcome
of patients with symptomatic fluid collections following liver resection and treated with
CT-guided drainage comprising a large patient cohort in order to enhance the evidence in
the assessment of this procedure.
2. Materials and Methods
2.1. Study Subjects
A database search of the Radiology Information System (RIS) for the specific procedure
key “CT-guided drainage of the liver” in our department was conducted. Indication for
previous liver surgery in the results was detected by a full text search of the corresponding
written reports as well as in the operations and procedure codes (OPS) of the Hospital
Information System (HIS). We evaluated patients with postoperative fluid collections who
had undergone liver surgery between 2004 and 2017 and who had received percutaneous
CT-guided drainage during a period of max. 60 days after surgery. Details of the selection
process are shown in Figure 1.
Figure 1. Flow chart of the patient selection process. n: number of patients
All interventional procedures performed in this study involving human participants
were in accordance with the Helsinki declaration of 1964 and with the ethical standards
of the institutional and/or national research committee and its later amendments or com-
parable ethical standards. Informed consent by the patients or his or her legal guardians
to undergo CT-guided drainage was usually obtained 24 hours before the intervention
and in case of emergency immediately before the procedure. This retrospective study was
approved by the local ethics committee (number 21-0114, Date: 2 February 2021).
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2.2. CT Imaging Protocol
All interventions were performed on a 64-slice (Siemens SOMATOM 64; Siemens
Healthineers, Erlangen, Germany) or on a 128-slice (Siemens SOMATOM Definition
AS+/Siemens SOMATOM Definition Edge) CT scanner, respectively. Each patient un-
derwent a pre-interventional CT scan to examine the exact position and size of the fluid
collection. The most suitable access path for the percutaneous drainage was planned on
these images. Drainage catheters with different diameters (Flexima®, Boston Scientific
Corporation, Marlborough, MA, USA and ReSolve®, Merit Medical, South Jordan, UT,
USA; respectively) were used depending on the access path and the experience of the
interventionalist. An unenhanced follow-up CT scan was performed immediately after
drainage catheter placement to evaluate the outcome of the intervention with respect to
the position of the drainage and potential peri-interventional complications. No contrast
media was administered. Images were reconstructed using a soft tissue convolution kernel
at a slice thickness of 3 mm.
2.3. Analysis of Pre- and Peri-Interventional Period
One board-certified radiologist experienced in abdominal imaging with 5 years’ expe-
rience assessed surgical techniques (hemihepatectomy, extended hemihepatectomy, minor
resection), techniques of intervention (Trocar technique, Seldinger technique), number of
drainages, diameter of drainage catheters, access trajectory for drainage (direct, transhep-
atic, transpleural) and peri-interventional complications (minor, major) according to the
Society of Interventional Radiology (SIR) [16]. The mean diameter of the fluid collections
was measured. Entities of the fluid collections were not differentiated.
Success in technical outcome after intervention was defined as (a) sufficient drainage
of the fluid collection (i.e., leaving less than 10% of the fluid collection after aspiration) and
(b) the non-occurrence of peri-interventional complications requiring surgical treatment
with minor (<48 h) or prolonged (>48 h) hospitalization [6], respectively.
Inflammatory blood parameters (C-reactive protein (CRP), leukocytes, interleukin-6)
and Total Serum Bilirubin (TSB) prior and post-intervention were measured to detect
possible superinfections.
The level of the patient radiation dose was provided by the CT scanner for every
interventional procedure step by use of the dose-length product (DLP (mGy*cm)). We
evaluated the summarized DLP of the pre-interventional planning CT scan, the sum of
all intra-interventional CT fluoroscopic acquisitions and of the post-interventional control
CT scan, if performed. The resulting DLPs were compared among the time intervals of
2004–2010 and 2011–2017.
2.4. Analysis of Post-Interventional Period
Patients receiving reoperation within 60 days after surgery due to insufficient drainage
of the fluid collections were evaluated.
The time course of the inflammatory parameters and TSB within 30 days after the
intervention was estimated in the subgroup of patients where no evidence of further
surgical interventions or complications could be found in the HIS. Based on these results,
the success in clinical outcome after the intervention was defined in either a decrease (>50%)
of the initially elevated parameters CRP, leukocyte count, and TSB or by the normalization
of these elevated parameters within 30 days after intervention, respectively. In addition,
clinical success was defined by the absence of necessity for surgical revision related to the
intervention. The clinical outcome determined in this way was then compared with the
applied surgical techniques to detect possible causal relations.
Microbiological results of the secretion delivered by the drainage catheters were
assessed. The number of days until the removal of the drainage was registered for each
patient. The removal of the drainage was based on the patient’s clinical and laboratory
response [17]. Follow-up imaging was performed only in patients who were not improving
clinically [18].
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2.5. Statistical Analysis
Discrete and continuous data were initially assessed for normality using the Shapiro–
Wilk test and by visual inspection of their histograms. Normally distributed variables
are provided as mean ± standard deviation (SD). Variables that do not follow normal
distribution are shown as median (25%-; 75%-quartiles).
To examine the time course of the blood parameters in the 30-days post-interventional
period, the values were log-transformed to achieve normal distribution. Then, generalized
linear mixed models (GLMM) were applied. The fixed effect was the number of days after
the intervention. Random intercepts were given by subject ID repeated by days.
The relation between surgical techniques and clinical outcome was assessed with
Fisher exact tests. Mann–Whitney tests for independent samples were used to determine
significant differences between the radiation exposure, which was found in the two periods.
Analysis was performed using R (R Core Team (2020). R: A language and environment
for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL
https://www.R-project.org/, version 4.0.2, accessed on 22 June 2020). A level of significance
of alpha = 0.05 was used throughout the study.
3. Results
Overall, 143 patients (87 males, mean age 59 ± 14 years) who underwent CT-guided
drainage interventions following liver resections between 2004 and 2017 were included in
this study. The fluid collections were located at the resection margins. Patients deceased
within 60 days after intervention due to reasons unrelated to the drainage procedure and
the fluid collection, respectively, were excluded from the analysis. Detailed information on
the patient collective is provided in Table 1.
Table 1. Population characteristics in 143 patients having undergone CT-fluoroscopy guided percuta-
neous drainage of fluid collections following liver resection.
Variable
Age (years) 59.8 ± 14.1 (16–83) 1
Sex
Female 56 (39.2) 2
Male 87 (60.8) 2
Max. Diameter of the fluid collection (cm) 8.7 ± 3.3 (3.0–20.0) 1
Indications for Liver Resection
Malignant disease: 125 (87.4%) 2
Liver metastases 70 (49.0%) 2
Hepatocellular carcinoma 30 (21.0%) 2
Klatskin Tumor 11 (7.7%) 2
Cholangiocellular carcinoma 9 (6.3%) 2
Other 5 (3.5%) 2
Benign disease: 13 (9.1%) 2
Echinococcus cyst 6 (4.2%) 2
Focal nodular hyperplasia 4 (2.8%) 2
Liver adenoma 2 (1.4%) 2
Hemangioma 1 (0.7%) 2
Inflammatory 5 (3.5%) 2
Surgery Techniques
Extended hemihepatectomy 36 (25.2%) 2
Hemihepatectomy 44 (30.8%) 2
Minor resection 63 (44.0%) 2
1: Mean value ± standard deviation (range), 2: Numbers (Percentage)
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3.1. Pre- and Peri-Interventional Analysis
Within an interval of 60 days after surgery, 189 interventions (mean ± SD: 1.3 ± 0.6)
per patient were performed. The Trocar technique was used in 174 interventions (92.1%),
and the Seldinger technique was used in 15 procedures (7.9%). Mean number of drainages
was 1.2 (SD: ±0.4) per intervention. Overall, 222 drainages were inserted. Diameters of
drainages were 8 French (F) in 77 cases (39.3%), 10F in 94 cases (48.0%), 12F in 20 cases
(10.2%) and 14F in 3 cases (1.7%). For 26 drainages, there was no information on the diam-
eters available. Direct access for drainage catheter placement was used in 131 drainages
(67.5%), transhepatic access in 62 drainage placements (32.0%) and transpleural access in
1 intervention (0.5%). For 28 drainages, these data were missing. Detailed information on
drainages and techniques of intervention is presented in Table 2.
Table 2. Information on drainages and intervention technique.











Technique Interventions (n, %)
Trocar 174 (92.1%)
Seldinger 15 (7.9%)




n: number; %: percentage.
In 186 interventions, the first placement of the drainage was successful. In two inter-
ventions, instant re-placement was necessary. One intervention could not be finished since
the fluid collection turned out to be too small for drainage placement. Overall, 188 inter-
ventions (99.5%) were technically successful (Figure 2).
Peri-interventional complications occurred in seven patients (4.1%), including four
major complications according to SIR (Table 3, Figure 3); operative revision was necessary
for two patients.
CRP at the day of the intervention (baseline) was 11.4 ± 6.8 mg/dL, leukocytes were
12.6 ± 6.4 × 109/L. nterleukin-6 (median (25%, 75% quartile)) was 143,9101.4, 358.3) pg/dL
and TSB was 1.2 (0.7, 2.1) mg/dL.
There were increased baseline levels of CRP (>0.5 mg/dL) in 131 interventions (91.6%),
of leukocytes (>9.8 × 109/L) in 60 interventions (51.5%) and of TSB (>1.0 mg/dL) in 58 inter-
ventions (44.6%), respectively. Interleukin-6 (>5.9 pg/dL) was elevated in 24 interventions.
Sepsis was detected in 16 patients (11.2%). However, the development of sepsis cannot
solely be correlated to the intervention in any case as most patients were multi-morbid.
DLP (median (25%, 75% quartile)) of the whole intervention was 745.5 (539.8, 1096.3)
mGy*cm between 2004–2010 and 536.0 (406.0, 787.5) mGy*cm between 2011–2017, which
was significantly different (Mann–Whitney-test p < 0.05). Comparing the parts of the
intervention, there was a significant (Mann–Whitney-test p < 0.05) reduction of radiation
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dose in pre- (years 2004–2010: 345 (242,617) mGy*cm vs. years 2011–2017: 280.0 (194.5,
406.5) mGy*cm) and intra-interventional (years 2004–2010: 85.5 (43.5, 221.3) mGy*cm vs.
years 2011–2017: 28.0 (17.8, 60.3) mGy*cm) CT scans.
The highest decrease was observed for CT fluoroscopy with a reduction of −67.3%
of the median value (Figure 4). DLP for the post-interventional control scan did not
differ significantly (years 2004–2010: 217 (164.3, 300.3) mGy*cm vs. years 2011–2017: 223
(174,298) mGy*cm; Mann–Whitney-test p > 0.05).
Figure 2. Example of a regular procedure of a CT-guided drainage placement. (A) A 64-year-old
man with a history of neuroendocrine tumor of the ileum with liver metastasis and previous left side
hemihepatectomy. MRI follow-up with hepatobiliary contrast media one year later revealed two new
small metastasis in segments 5 and 8 (arrowheads). (B) The patient developed fever 5 days after the
atypical resection of the liver segments 5 and 8. CT revealed fluid collection and small gas bubbles
in the resection cavity, indicating an abscess formation. Arrowheads: resection margins. (C) CT
fluoroscopic image with drainage (arrow) placement. Arrowheads: resection margins. (D) Post-
interventional CT control scan. After placement of a 10 F drainage (arrow) and aspiration, the size of
the fluid collection becomes significantly smaller. Arrowheads: resection margins. (E) MRI follow-up
six months later showed unsuspicious resection margins (arrowheads) with granulation tissue.
Table 3. Peri-interventional complications according to SIR.
Type of Complication Interventions (n, %)
Minor complications: 3 (1.6%)
Small pneumothorax 3
Major complications: 4 (2.1%)
Severe pneumothorax
(requiring surgical management) 1
Hemorrhage 1
Laceration (colon, liver) 2
n: number; %: percentage.
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Figure 3. Example of an intervention with complications according to SIR. (A) A 72-year-old male after
left side hemihepatectomy due to a cholangiocellular carcinoma. Thirteen days after the operation, the
patient presented with fever, epigastric pain and elevated inflammatory blood parameters. CT revealed
a large fluid collection in the resection area (star). (B) CT fluoroscopy-guided placement of a 10 F
drainage (arrow) within the fluid collection (star). (C) Unenhanced CT post-interventional control scan
showed blood collections in the paragastric area and in the right upper quadrant (arrowheads). Arrow:
drainage. Star: fluid collection. (D) An additional CT scan with arterial contrast revealed extravasation
(dotted arrow). Arrow: drainage. Star: fluid collection. (E) Workup of the incident showed an injury
of the right gastroepiploic artery (dashed arrow). The reason was a restless and uncompliant patient.
Due to patient movements, the trajectory was not carried out as planned. Star: fluid collection. (F) An
immediately performed digital subtraction angiography (DSA) confirmed extravasation of contrast
agent from the right gastroepiploic artery (arrowheads). (G) Treatment of the bleeding was performed
with an endovascular placement of seven microcoils in a sequence (arrowheads).
3.2. Post-Interventional Analysis
Twenty-five patients had to be excluded from further analysis. Twelve patients
deceased within 60 days after intervention for reasons not related to the intervention,
for example, respiratory insufficiency. In 12 patients, data of laboratory values were too
sparse or inconsistent. In one patient, CT-guided drainage was not successful. Overall,
116 interventions could be included in the post-interventional analysis.
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Figure 4. Boxplots of the median radiation dose between the time intervals of the years 2004–2010
and years 2011–2017 for parts of the interventional CT scan and for the whole procedure. (*) indicate
significant group differences.
The time course of CRP, leukocytes and TSB revealed a statistically significant (p < 0.05)
decrease within 30 days after intervention when analyzed with GLMMs in the sub-
group of patients with no evidence of further surgical interventions or complications.
The log-transformed values decreased with an average of −0.00574 mg/dL for TSB,
−0.01559 mg/dL for CRP and −0.00483 × 109/L for leukocytes, respectively (Figure 5
and Table 4). However, values of Interleukin-6 showed no significant decrease in this
subgroup; therefore, this factor was not included in our further evaluations.
Figure 5. Development of laboratory parameters within 30 days after the intervention in subjects
with no evidence of further surgical interventions or complications in the patient record. Please add
short explanations titles for (A–D).
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Table 4. Parameters of the generalized linear mixed models used in Figure 4.
CRP Leukocyte Count Interleukin-6 Total Serum Bilirubin
Predictors Estimates CI p Estimates CI p Estimates CI p Estimates CI p
(Intercept) 0.77 0.70–0.84 <0.001 0.96 0.92–0.99 <0.001 1.99 1.73–2.24 <0.001 −0.02 −0.10–0.06 0.656
Time (days) −0.02 −0.02–−0.01 <0.001 −0.00 −0.01–−0.00 <0.001 −0.01 −0.02–0.00 0.132 −0.01 −0.01–−0.00 <0.001
Random Effects:
σ2 0.10 0.02 0.11 0.02
τ00 0.12 Subject ID 0.02 Subject ID 0.18 Subject ID 0.16 Subject ID
ICC 0.54 0.51 0.61 0.88
N 112 Subject ID 88 Subject ID 14 Subject ID 108 Subject ID
Observations 835 609 112 635
Marginal R2/
Conditional R2
0.076/0.572 0.041/0.526 0.013/0.615 0.013/0.884
CI: Confidence interval; R2: Coefficient of Determination; σ2: distribution-specific variance; τ00: between-subject variance; ICC: intraclass
correlation coefficient, N: number of subjects. P-values in bold indicate significant effects.
Clinical success by our definition of decrease of initially elevated laboratory parame-
ters was reached for CRP in 97/131 interventions (74.0%) after (median (25%, 75% quartile))
6.0 (4.0, 10.0) days, for leukocytes in 52/60 interventions (86.7%) after 3.5 (2.0, 8.0) days
and for TSB in 36/58 interventions (62.1%) after 5.5 (2.8, 11.0) days, respectively. The distri-
bution of the success rate among the different applied surgical procedures in the patients
is shown in Table 5. For CRP, the values were relatively close to each other. Patients with
right-sided hemihepatectomy had the worst outcome of the success rate for leukocytes and
TSB (33.3% and 44.4%, respectively). However, findings were not statistically significant
(Fisher exact test p > 0.05).
Table 5. Distribution of the success rate in terms of decreasing laboratory parameters among the different applied
surgical procedures.



















Hemihepatectomy 29 20 (69.0) 9 (31.0) 16 11 (68.8) 5 (31.2) 17 14 (82.4) 3 (17.6)
Left Hemihepatectomy 14 9 (64.3) 5 (35.7) 6 5 (83.3) 1 (16.7) 7 5 (71.4) 2 (28.6)
Right Hemihepatectomy 20 13 (65.0) 7 (35.0) 9 3 (33.3) 6 (66.7) 9 4 (44.4) 5 (55.6)
Minor Resection 43 34 (79.1) 9 (20.9) 21 16 (76.2) 5 (23.8) 15 11 (73.3) 4 (26.7)
Total 106 76 (71.7) 30 (28.3) 52 35 (67.3) 17 (32.7) 48 34 (70.8) 14 (29.2)
n: number; %: percentage.
With regard to a successful clinical outcome in terms of a necessary reoperation, in
14 (9.8%) patients, a surgical revision had to be conducted due to insufficient drainage of
the fluid collection. This comprised five patients with extended hemihepatectomy and
nine patients with minor resections and was not statistically significant (Fisher exact test
p = 0.089).
Microbiological results of wound secretions were positive in 81 (74.3%) and negative
in 35 (32.1%) patients. The most common strains of detected bacteria were Enterococci in
54 patients and Staphylococci in 29 patients, respectively. The most frequent pathogen of
fungus infection was Candida in 36 patients. For a detailed presentation of the microbio-
logical results, please see Supplementary Figure S1.
The distribution of the success rate between infected and non-infected fluid collections
is shown in Table 6. The proportion of successfully reduced laboratory parameter values
tended to be higher in patients with infected fluid collections and was highest with 82.9%
for leukocyte count.
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Table 6. Distribution of the success rate in terms of decreasing laboratory parameters between infected and non-infected
fluid collections.





















Infected 79 61 (77.2) 18 (22.8) 41 34 (82.9) 7 (17.1) 33 22 (66.7) 11 (33.3)
Non-infected 31 23 (74.2) 8 (25.8) 11 6 (54.5) 5 (45.5) 15 9 (60.0) 6 (40.0)
Total 110 84 (76.4) 26 (23.6) 52 40 (76.9) 12 (23.1) 48 31 (64.6) 17 (35.4)
n: number; %: percentage.
Two out of thirty-five (2.9%) patients with non-infected fluid-collections underwent
surgical revision due to insufficient drainage. This was a lower rate than in patients with
infections, where in 11/81 (13.6%) patients, resurgery was performed. However, these
findings were not statistically significant (Fisher exact test p > 0.05).
The mean duration time until the removal of the drainage was 14.2 ± 13.7 days.
4. Discussion
Hepatic resection has had an impressive growth over time and has been widely
performed for the treatment of various liver diseases, such as malignant tumors, benign
tumors, and abscesses [19]. The management of complications is challenging. Formation of
intraabdominal fluid collections like abscess, biloma, lymphocele, hematoma and seroma
following liver resection frequently occur [1]. Its incidences show larger ranges of variation
in the literature: for example, Jin et al. reported an occurrence of bile leakage between 4%
and 17% [19]. Brustia et al. found postoperative fluid collections after liver surgery in 53.6%
of their patients with 12% requiring drainage [20]. In the population studied by Benzoni
et al., hepatic abscess was observed in 25% [21]. Abscesses, in particular, are associated
with significant morbidity and mortality [4,8], requiring an early and successful treatment.
Ultrasound-guided drainage is advantageous if the fluid collection can be confidently
visualized. The procedure can then be monitored in real time, without radiation exposure
and at low cost. However, it is highly dependent on the experience of the operator and
is often not suitable for liver abscesses located in difficult-to-access sites. In addition to
antibiotic therapy, CT-guided percutaneous drainage, therefore, has become an alternative
for surgery and is currently the standard of treatment [5]. Compared to open surgical
drainage, it is less invasive, more cost-effective and can be used repeatedly [9]. Moreover,
CT-guided drainage enables both identification of causative microorganisms and targeted
treatment in cases of superinfection.
Our retrospective study spanned a period of 14 years and included a large cohort of
patients who received CT-guided percutaneous drainage interventions after liver resections.
A total of 143 patients with a total of 189 interventions were analyzed in terms of technical
and clinical outcomes. Most patients received one drainage per intervention. The trocar
technique as a single-step procedure is easier and more economical to apply compared with
the drainage procedure conducted using Seldinger techniques and was more frequently
used in our patients [22]. As the postoperative fluid collections were mostly superficial,
direct access (67.5%) was more frequently used than transhepatic (32.0%) or transpleural
access (0.5%), respectively.
CT-guided drainage procedures may result in various complications, such as pneu-
mothorax, hemorrhage, sepsis or death [5,12,13,15]. Prior studies reported complication
rates of around 10% [23]. In our study, the rate of peri-interventional complications was
slightly lower as they occurred in seven patients (4%), including four major complications
according to SIR [16]. In terms of technical success, 98% of interventions were successful in
our study. This is in agreement with other authors who reported a high technical success
rate of interventional drainage of abdominal abscess with a range of 95–100% [7,10,11].
The cure rates of abdominal abscesses depend on their complexity. Simple abscesses
that are unilocular and discrete are reported to be cured in more than 90% of the cases,
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whereas more complicated collections, such as those with enteric fistulas or pancreatic
abscesses, show cure rates of 65% to 90% [5].
In our study, a successful clinical outcome was defined as either a decrease of elevated
inflammation parameters (>50%) CRP, leukocyte count and TSB or normalization of these
parameters within 30 days after the intervention, respectively. Interleukin-6 was excluded
since a preceding analysis in a subgroup of patients with no apparent complications or
abnormalities in the patient record showed that this parameter did not decrease significantly
during this follow-up period in our cohort. However, this is possible due to the small
number of 14 patients (n = 14) for which the corresponding interleukin-6 values were
available from the records. Clinical success according to the above definition was most
frequently observed for the parameter leukocytes (86.7% of the interventions), followed
by CRP (74.0%) and TSB (62.1%). Clinical success often occurred within the first week
(median: after 3.5 days for Leukocytes, 5.5 for TSB and 6.0 days for CRP, respectively).
Furthermore, in our study, it was considered as a clinical success if surgical revision related
to the intervention was not necessary (90.2%). Clinical success rates determined with our
criteria are comparable to the findings of other authors: Akinci et al. investigated the
efficacy of percutaneous drainage of intraperitoneal abscesses in 255 patients. Initial cure
rates were 68%, defined as complete healing without any need for recatheterization [23]. In
contrast to our study, abscesses were drained either with fluoroscopic, sonographic or CT
guidance. In another study, which evaluated 47 patients with 54 drainages in abdominal,
retroperitoneal and pelvic abscesses, respectively, clinical success was achieved in 94%
of the patients [7]. Lagana et al. evaluated 95 patients with 107 abdominal and pelvic
abscesses and obtained clinical success in 92% of the cases [11].
We did not find a significant correlation comparing clinical outcome and preceding
operation techniques. This indicates that the postoperative course of the patients was not
negatively influenced by more extensive surgical techniques.
In our study, a significant reduction of median DLP was observed in the pre- and peri-
interventional CT scans comparing the years 2004–2010 and the years 2011–2017, especially
for CT fluoroscopy. This is probably due to ongoing technical developments of CT, includ-
ing accelerated image acquisition, improved spatial resolution, tube current modulation
and the improvement of image quality by iterative image reconstruction [24–26]. Another
point is the more frequent use of CT-guided drainage over time, leading to increased
experience of the interventional radiologists [27]. This reduces the CT acquisition time that
is required for trajectory planning and drainage placement.
Regarding microbiological results, the most frequently isolated bacteria of wound
secretions of the drainages were Enterococci, followed by Staphylococci, Klebsiella pneu-
moniae and E. coli. The most frequent pathogen of fungus was Candida. Overall, this
corresponds to pathogens that commonly predominate in intraabdominal infections [28,29].
In our study, infected fluid collections showed a tendency for higher clinical success rates
in comparison to non-infected fluid collections when treated with CT-guided drainage.
This could be an indication that drainage is slightly more effective by relieving pus than by
removing a solely mechanical accumulation of fluid, such as in a biliary leak.
Several limitations of our study have to be considered. First, we included the occur-
rence of sepsis within the outcome analysis. Since most patients were multimorbid, the
development of sepsis cannot be clearly assigned to the intervention. Second, we did not
differentiate between the entities of the fluid collections since this was not the aim of our
study. Third, several patients had to be excluded retrospectively from analysis due to
missing or incomplete data.
5. Conclusions
In conclusion, patients with symptomatic fluid collections following liver resection
who underwent percutaneous CT-guided drainage showed a very high technical success
rate (99.5%) and a fair-to-good clinical success rate, when assessed by the decrease of
blood parameters (CRP: 74.0%, leukocytes 86.7%, TSB 62.1%, respectively) or the absence
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of necessity for surgical revisions related to the intervention (90.2%). Results were not
influenced by the complexity of preceding surgical procedures. Compared to open surgery
drainage, CT-guided drainage involves far fewer complications and can be used repeatedly.
In addition, it enables both pathogen identification and targeted treatment in cases of su-
perinfection. Technical developments of CT and increased experience of the interventional
radiologists resulted in reduced radiation exposure over the years.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/diagnostics11050826/s1, Figure S1: Microbiological results in wound secretions divided
into the different strains of bacteria and fungi.
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8. Men, S.; Akhan, O.; Köroğlu, M. Percutaneous drainage of abdominal abcess. Eur. J. Radiol. 2002, 43, 204–218. [CrossRef]
9. Roberts, B.W. CT-guided Intra-abdominal Abscess Drainage. Radiol. Technol. 2015, 87, 187.
10. Kim, Y.J.; Han, J.K.; Lee, J.M.; Kim, S.H.; Lee, K.H.; Park, S.H.; An, S.K.; Lee, J.Y.; Choi, B.I. Percutaneous Drainage of Postoperative
Abdominal Abscess with Limited Accessibility: Preexisting Surgical Drains as Alternative Access Route. Radiology 2006, 239,
591–598. [CrossRef] [PubMed]
11. Laganà, D.; Carrafiello, G.; Mangini, M.; Ianniello, A.; Giorgianni, A.; Nicotera, P.; Fontana, F.; Dionigi, G.; Fugazzola, C.
Image-guided percutaneous treatment of abdominal-pelvic abscesses: A 5-year experience. La Radiol. Med. 2008, 113, 999–1007.
[CrossRef] [PubMed]
12. Gee, M.S.; Kim, J.Y.; Gervais, D.A.; Hahn, P.F.; Mueller, P.R. Management of Abdominal and Pelvic Abscesses That Persist Despite
Satisfactory Percutaneous Drainage Catheter Placement. Am. J. Roentgenol. 2010, 194, 815–820. [CrossRef] [PubMed]
13. Gervais, D.A.; Ho, C.-H.; O’Neill, M.J.; Arellano, R.S.; Hahn, P.F.; Mueller, P.R. Recurrent Abdominal and Pelvic Ab-
scesses:Incidence, Results of Repeated Percutaneous Drainage, and Underlying Causes in 956 Drainages. Am. J. Roentgenol. 2004,
182, 463–466. [CrossRef] [PubMed]
Diagnostics 2021, 11, 826 13 of 13
14. Maher, M.M.; Gervais, D.A.; Kalra, M.K.; Lucey, B.; Sahani, D.V.; Arellano, R.; Hahn, P.F.; Mueller, P.R. The Inaccessible or
Undrainable Abscess: How to Drain It. Radiographics 2004, 24, 717–735. [CrossRef]
15. Nattenmüller, J.; Filsinger, M.; Bryant, M.; Stiller, W.; Radeleff, B.; Grenacher, L.; Kauczor, H.-U.; Hosch, W. Complications in
CT-guided Procedures: Do We Really Need Postinterventional CT Control Scans? Cardiovasc. Interv. Radiol. 2013, 37, 241–246.
[CrossRef]
16. Gupta, S.; Wallace, M.J.; Cardella, J.F.; Kundu, S.; Miller, D.L.; Rose, S.C. Quality Improvement Guidelines for Percutaneous
Needle Biopsy. J. Vasc. Interv. Radiol. 2010, 21, 969–975. [CrossRef]
17. Serraino, C.; Elia, C.; Bracco, C.; Rinaldi, G.; Pomero, F.; Silvestri, A.; Melchio, R.; Fenoglio, L.M. Characteristics and management
of pyogenic liver abscess. Medicine (Baltimore) 2018, 97, e0628. [CrossRef]
18. Dulku, G.; Mohan, G.; Samuelson, S.; Ferguson, J.; Tibballs, J. Percutaneous aspiration versus catheter drainage of liver abscess:
A retrospective review. Australas. Med. J. 2015, 8, 7–18. [CrossRef] [PubMed]
19. Jin, S.; Fu, Q.; Wuyun, G.; Wuyun, T. Management of post-hepatectomy complications. World J. Gastroenterol. 2013, 19, 7983–7991.
[CrossRef]
20. Brustia, R.; Fleres, F.; Tamby, E.; Rhaiem, R.; Piardi, T.; Kianmanesh, R.; Sommacale, D. Postoperative collections after liver
surgery: Risk factors and impact on long-term outcomes. J. Visc. Surg. 2020, 157, 199–209. [CrossRef]
21. Benzoni, E.; Cojutti, A.; Lorenzin, D.; Adani, G.L.; Baccarani, U.; Favero, A.; Zompicchiati, A.; Bresadola, F.; Uzzau, A. Liver
resective surgery: A multivariate analysis of postoperative outcome and complication. Langenbeck’s Arch. Surg. 2006, 392, 45–54.
[CrossRef] [PubMed]
22. Turan, H.G.; Özdemir, M.; Acu, R.; Küçükay, F.; Özdemir, F.A.E.; Hekimoğlu, B.; Yıldırım, U.M. Comparison of seldinger and
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